CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently commented on. Cramer praised the company’s CEO during the episode, as he commented: “This stock has become the best performer ...

CVS Health (CVS) stock in focus as the company raises 2025 financial guidance, but projects 2026 revenue below consensus.

CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter 2025 results. Despite concerns over the company’s decision to implement ...

CVS Health’s CVS stock has gained strong momentum so far in 2025, rising 47.1%. While operating income declined nearly 5% in the fourth quarter of 2024 (as reported last month), impacted by continued ...

Shares of CVS Health (CVS) and other health-related companies lost more than 5% on Wednesday after a bipartisan group of senators announced sponsorship of legislation to break up the relationship ...

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

CVS Health CVS has recently announced the offering of measles-mumps-rubella (MMR) vaccine to residents post the current outbreak in South Carolina. Both CVS Pharmacy stores and MinuteClinic walk-in ...

If you are wondering whether CVS Health is still a bargain after its big run this year, or if the easy money has already been ...

Shares of CVS Health were headed for their best day in more than five months as all of its business segments saw double-digit percentage revenue growth Shares of CVS Health Corp. shot higher in early ...

Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday, February 12. Wall Street estimates fourth-quarter adjusted EPS of $0.94 and sales of ...